Kenya HIV Market Analysis


  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4841

  • Format: PPT, PDF

Kenya HIV/AIDS Drug Market Segmented by Drug Class (Multi-class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors & Entry Inhibitors and Integrase Inhibitors) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4841 Categories: ,

Report Overview

The HIV/AIDS drugs market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Kenya market for HIV/AIDS treatment has been expanding owing to the high burden of disease in the country. Kenya is home to one of the world’s worst HIV and AIDS epidemics. Approximately 1.5 million people are living with HIV in 2019, and an estimated 1 million children have been orphaned by the virus. Although, the prevalence has declined, now stands at 4.7% according to CDC (Centre of Disease Control), many people in Kenya are still not being reached with HIV prevention and treatment services. According KENPHIA, the prevalence of HIV in women is at 6.6%, twice that in men at 3.1%. The gender disparity in the burden of HIV is even greater than 3 times in between the ages of 20-34 years. High prevalence in the country may be attributed to low levels of awareness about HIV risk among women, increase in people who inject drugs and unprotected sex with injected persons.

Market Drivers

Kenya HIV Diagnosis & Treatment Market is growing moderately due to decline in the prevalence of HIV/AIDS. The prevalence has declined from 6.7% in 2004 to 4.7% in 2019.

HIV/AIDS drug market is driven by the high burden of HIV/AIDS. Kenya has the third-largest HIV epidemic in the world with approximately 1.5 million people living with HIV/AIDS.  In addition, increasing product pipeline for treating HIV/AIDS expected to create high demand. HIV/AIDS treatment market is driven by increasing governments and regulatory bodies support by means of research and development investment, fast track approval for newer treatments for this disease.

Kenya’s health authorities have launched a new way to reduce the spread of HIV among its people. This is pre-exposure prophylaxis (PrEP), joins other prevention and treatment methods already in use in Kenya.

It involves giving antiretroviral (ARV) drugs to people who are not infected with HIV but are at high risk of infection. Taking the drug reduces the chances of HIV infection.

Low rate of voluntary screening for the disease is a major restraint for the market. Awareness about diagnostic tests for HIV infection is extremely low in countries in Africa. Hence, companies are facing challenges in penetrating the market in the region. Moreover, several low- and middle-income countries depend on government grants for provision of rapid diagnostic tests in the event of an epidemic. Therefore, their direct reach to customers is weak. These factors hamper the market in the region.


1. Kenya HIV/AIDS Drugs Market Overview……………………………………………..
A. Market Size
2. Market Growth Drivers…………………………………………………………………
A. High Burden of HIV/AIDS in Kenya
B. Growing R&D Investments and Government Initiatives to Reduce the Disease Burden.
3. Epidemiology……………………………………………………………………………
A. Prevalence of HIV/AIDS in Kenya
B. Incidence of HIV/AIDS in Kenya
4. HIV/AIDS Drugs Market Segmentation……………………………………………….
A. Drug Class
I. Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
II. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
III. Entry & Fusion Inhibitors
IV. Protease inhibitors (PIs)
V. Integrase Inhibitors
VI. Multi-Class Combination Drugs.
I. Others
B. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online
IV. Others
5. HIV/AIDS Major Drugs Market Share……………………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape……………………………………………………………..
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………
A. Abbott Laboratories Company overview, Product & Services, Strategies & Financials
B. GlaxoSmithKline (GSK) Company overview, Product & Services, Strategies & Financials
C. Johnson & Johnson Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………..….
A. New Trends and Development of HIV/AIDS drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

Based on class, the market has been segmented into multi-class combination drugs, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors and entry inhibitors and HIV integrase strand transfer inhibitors.

Multi-Class combination drugs and nucleoside reverse transcriptase inhibitors hold the dominant share in the market.

 By Distribution Channel:

On the basis of distribution channel, the market for HIV/AIDS drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.

The hospital segment is expected to dominate the market throughout the forecast period.

 Major Players

Major companies operating in the HIV/AIDS drug market in Kenya are Abbott Laboratories (US), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (US), Cipla Inc. (India), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), Johnson & Johnson Services (US), and Merck & Co. (US).

ViiV Healthcare Limited is a joint venture by Pfizer and GlaxoSmithKline specializing in development of HIV therapies. Triureq and Tivicay are the most common first line treatment drugs in HIV in Kenya are manufactured by Viiv Healthcare Limited.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements